Co-injection of human PSCs enhanced tumorigenicity significantly (Fig. 4i–l), while neutralization of activin A with anti-activin A antibody or follistatin significantly decreased tumor growth only in cases where PSCs were also injected (Fig. 4i–l). This evidence concerns the gene FST and neoplasm.